UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14C INFORMATION
Information
Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934
Check
the appropriate box:
[X]
Preliminary Information Statement
[ ]
Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)2))
[ ]
Definitive Information Statement
THE
GREATER CANNABIS COMPANY, INC.
(Name
of Registrant as Specified in Charter)
Payment
of Filing Fee (Check the appropriate box):
[X]
No fee required
[ ]
Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11
1.
Title of each class of securities to which transaction applies:
2.
Aggregate number of securities to which transaction applies:
3.
Per unit price or other underlying value of transaction, computed pursuant to Exchange Act Rule O-11 (Set forth the amount on
which the filing fee is calculated and state how it was determined):
4.
Proposed maximum aggregate value of transaction:
5.
Total fee paid:
[ ]
Fee paid previously with preliminary materials.
[ ]
Check box if any part of the fee is offset as provided by Exchange Act Rule O-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of
its filing.
1.
Amount Previously Paid:
2.
Form Schedule or Registration Statement No.:
3.
Filing Party:
4.
Date Filed:
SCHEDULE
14C INFORMATION STATEMENT
Pursuant
to Regulation 14C of the Securities Exchange Act
of
1934, as amended
The
Greater Cannabis Company, Inc.
15
Walker Avenue, Suite 101
Baltimore, MD 21208
GENERAL
INFORMATION
This
Information Statement (the “Information Statement”) has been filed with the Securities and Exchange Commission and
is being furnished, pursuant to Section 14C of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
to the holders (the “Stockholders”) of the common stock, par value $.001 per share (the “Common Stock”),
of The Greater Cannabis Company, Inc., a Florida Corporation (the “Company”), to notify such Stockholders that on
or about August 1, 2019, the Company received written consents in lieu of a meeting of Stockholders from holders of 500,000,000
shares of voting securities representing approximately 62% of the shares of the total issued and outstanding shares of voting
stock of the Company (the “Majority Stockholders”) to authorize the Company’s Board of Directors to approve
the following:
(1)
to authorize the Company to issue three new classes of preferred stock with such rights, terms and features as the Board of Directors
determine in its sole discretion with each new class to consist of 10,000,000 shares of preferred stock (the “Preferred
Stock Transaction”).
On
August 1, 2019, the Board of Directors of the Company approved the Preferred Stock Transaction, subject to Stockholder approval.
The Majority Stockholders approved the Increase by written consent in lieu of a meeting on August 1, 2019. Accordingly, your consent
is not required and is not being solicited in connection with the approval of the Increase. The Increase will become effective
when we file the Certificate of Amendment (the “Amendment”) with the Secretary of State of the State of Florida twenty
(20) days after the Definitive Information Statement is filed and mailed to Stockholders of Record. The Increase is not in any
way related to any plans or intentions to enter into a merger, consolidation, acquisition or similar business transaction.
WE
ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND A PROXY.
Dated:
August 5, 2019
For
the Board of Directors of
The Greater Cannabis Company, Inc.
|
|
|
|
|
By:
|
/s/ Aitan Zacharin
|
|
|
Aitan
Zacharin
|
|
|
Chief Executive Officer and Director
|
|
RECOMMENDATION
OF THE BOARD OF DIRECTORS
ACTIONS
TO BE TAKEN
ACTION
I – AUTHORIZATION OF THE CREATION OF THREE NEW CLASSES OF PREFERRED SHARES – THE SERIES B, SERIES C AND SERIES D CONVERTIBLE
PREFERRED SHARES
The
Board of Directors has determined that it will be necessary to authorize the creation of the Series B, Series C and Series D classes
of preferred stock with each class to have such rights, terms and features as the Board may determine in its sole discretion.
These classes of convertible preferred stock will provide the Company flexibility to restructure existing indebtedness and other
outstanding securities and to consummate such financing transactions as are required until it can become cash-flow positive. The
creation of the Series B, Series C and Series D classes of convertible preferred stock is hereinafter referred to as the “Preferred
Stock Transaction”)
Purpose
of the Increase
On
August 1, 2019, the Company’s Board of Directors and the Majority Stockholders owning a majority of the Company’s
voting securities approved a resolution authorizing the Company to amend the Articles of Incorporation to effect the Preferred
Stock Transaction. The Board believes that the Preferred Stock Transaction will provide the Company the flexibility to to restructure
existing indebtedness and other outstanding securities and to consummate such financing transactions as are required until it
can become cash-flow positive. The Preferred Stock Transaction is not in any way related to any plans or intentions to enter into
a merger, consolidation, acquisition or similar business transaction.
Amended
Certificate of Incorporation
Upon
the effectiveness and on the date that is twenty (20) days following the mailing of this Information Statement, the Board of Directors
shall have the Company’s Certificate of Amendment to the Articles of Incorporation filed with the State of Florida in order
to effect the Increase.
ADDITIONAL
INFORMATION
The
Company is subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and in accordance therewith files reports, proxy statements and other information including annual and quarterly reports on Form
10-K and 10-Q (the “1934 Act Filings”) with the Securities and Exchange Commission (the “Commission”).
Reports and other information filed by the Company can be inspected and copied at the public reference facilities maintained at
the Commission at Room 1024, 450 Fifth Street, N.W., Washington, DC 20549. Copies of such material can be obtained upon written
request addressed to the Commission, Public Reference Section, 450 Fifth Street, N.W., Washington, D.C. 20549, at prescribed rates.
The Commission maintains a web site on the Internet (http://www.sec.gov) that contains reports, proxy and information statements
and other information regarding issuers that file electronically with the Commission through the Electronic Data Gathering, Analysis
and Retrieval System (“EDGAR”).
The
following documents as filed with the Commission by the Company are incorporated herein by reference:
1.
Annual Report on Form 10-K for the year ended December 31, 2018; and
2.
Quarterly Report on Form 10-Q for the quarter ended March 30, 2019.
The
Company shall provide, without charge, to each person to whom an Information Statement is delivered, upon written or oral request
of such person and by first class mail or other equally prompt means within one (1) business day of receipt of such request, a
copy of any and all of the information that has been incorporated by reference in the Information Statement (not including exhibits
to the information that is incorporated by reference unless such exhibits are specifically incorporated by reference into the
information that the Information Statement incorporates), and the address and telephone numbers to which such a request is to
be directed.
INTEREST
OF CERTAIN PERSONS IN OR OPPOSITION TO MATTERS TO BE ACTED UPON
Except
as disclosed elsewhere in this Information Statement, none of the following persons have any substantial interest, direct or indirect,
by security holdings or otherwise in any matter to be acted upon:
1.
any director or officer of our Company since January 1, 2018 being the commencement of our last completed financial year;
2.
any proposed nominee for election as a director of our Company; and
3.
any associate or affiliate of any of the foregoing persons.
The
shareholdings of our directors and officers are set forth below in the section entitled “Security Ownership of Certain Beneficial
Owners and Management.” To our knowledge, no director has advised that he intends to oppose the Increase as more particularly
described herein.
OUTSTANDING
VOTING SECURITIES
Our
authorized capital stock consists of 500,000,000 shares of Common Stock, par value $0.001 per share, of which 35,272,483 shares
were outstanding as at August 2, 2019 and 10,000,000 shares of Series A Convertible Preferred Stock, par value $0.001 (the “Record
Date”).
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The
following information table sets forth certain information regarding the Company’s common stock owned on the Record Date
by (i) each who is known by the Company to own beneficially more than 5% of its outstanding Common Stock, (ii) each director and
officer, and (iii) all officers and directors as a group:
The
following table lists, as at the date hereof, the number of shares of common stock of our Company that are beneficially owned
by (i) each person or entity known to our Company to be the beneficial owner of more than 5% of the outstanding common stock;
(ii) each officer and director of our Company; and (iii) all officers and directors as a group. Information relating to beneficial
ownership of common stock by our principal shareholders and management is based upon information furnished by each person using
“beneficial ownership” concepts under the rules of the Securities and Exchange Commission. Under these rules, a person
is deemed to be a beneficial owner of a security if that person has or shares voting power, which includes the power to vote or
direct the voting of the security, or investment power, which includes the power to vote or direct the voting of the security.
The person is also deemed to be a beneficial owner of any security of which that person has a right to acquire beneficial ownership
within 60 days. Under the Securities and Exchange Commission rules, more than one person may be deemed to be a beneficial owner
of the same securities, and a person may be deemed to be a beneficial owner of securities as to which he or she may not have any
pecuniary beneficial interest. Except as noted below, each person has sole voting and investment power.
Name of Beneficial Owner
|
|
Common Stock
Beneficially
Owned(1)
|
|
|
Percentage of
Common
Stock (1)
|
|
Wayne Anderson
|
|
|
6,019,016
|
|
|
|
17.06
|
%
|
TD Ameritrade
|
|
|
4,468,537
|
|
|
|
12.66
|
%
|
Emet Capital Partners
|
|
|
10,384,600
|
|
|
|
29.44
|
%
|
Aitan Zacharin (2)
|
|
|
84,766,650
|
|
|
|
70.06
|
%
|
Mark Radom (2)
|
|
|
74,166,650
|
|
|
|
67.58
|
%
|
Elisha Kalfa (2)
|
|
|
74,166,650
|
|
|
|
67.58
|
%
|
Joe Kalfa (2)
|
|
|
74,166,650
|
|
|
|
67.58
|
%
|
Fernando Bisker (2)
|
|
|
74,166,650
|
|
|
|
67.58
|
%
|
Sigalush LLC (2)
|
|
|
74,166,650
|
|
|
|
67.58
|
%
|
David Tavor (2)
|
|
|
15,000,000
|
|
|
|
29.83
|
%
|
Officers and directors as a Group (2)
|
|
|
173,933,300
|
|
|
|
83.13
|
%
|
(1)
Beneficial Ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes
voting or investment power with respect to securities. Shares of common stock subject to options, warrants, convertible debt or
convertible preferred shares currently exercisable or convertible, or exercisable or convertible within 60 days of August 5, 2019
are deemed outstanding for computing percentage of the person holding such option or warrant but are not deemed outstanding for
computing the percentage of any other person. Percentages are based on a total of shares of common stock outstanding on August
5, 2019, which was 35,272,483, and the shares issuable upon exercise of options, warrants exercisable, preferred stock and debt
convertible on or within 60 days of August 5, 2019.
(2)
The shares included under “Officers and Directors as a Group” include those held by Aitan Zacharin, the Company’s
chief executive officer, Mark Radom, the Company’s general counsel and David Tavor, director. Aitan Zacharin holds 1,695,333
shares of Series A Convertible Preferred Stock, Mark Radom holds 1,483,333 shares of Series A Convertible Preferred Stock and
David Tavor holds 300,000 shares of Series A Convertible Preferred Stock. Each share of Series A Convertible Preferred Stock is
convertible into 50 shares of common stock.
DISSENTER’S
RIGHTS OF APPRAISAL
The
Stockholders have no right under Florida Corporate Law, the Company’s Articles of Incorporation consistent with above, or
Bylaws to dissent from any of the provisions adopted in the Amendment.
ANTI-TAKEOVER
EFFECTS OF THE PROPOSED INCREASE
Release
No. 34-15230 of the staff of the Securities and Exchange Commission requires disclosure and discussion of the effects of any stockholder
proposal that may be used as an anti-takeover device. Although the Company has no intent or plan to employ the additional unissued
authorized shares as an anti-takeover device, it is possible that management could use the additional shares to resist or frustrate
a third-party transaction providing an above-market premium that is favored by a majority of the independent stockholders. For
example, shares of authorized and unissued common stock could (within the limits imposed by applicable law) be issued in one or
more transactions that would discourage persons from attempting to gain control of the Company, by diluting the voting power of
shares then outstanding. Similarly, the issuance of additional shares to certain persons allied with the Company’s management
could have the effect of making it more difficult to remove the Company’s current management by diluting the stock ownership
or voting rights of persons seeking to cause such removal. Each of these, together with other anti-takeover provisions in our
charter documents and provided by Florida law, could potentially limit the opportunity for the Company’s stockholders to
dispose of their stock at a premium.
The
Company’s articles of incorporation and by-laws do not presently contain any provisions having anti-takeover effects and
this proposal is not a plan by management to adopt a series of amendments to the Company’s articles of incorporation or
by-laws to institute an anti-takeover provision. The Company does not have any plans or proposals to adopt other provisions or
enter into other arrangements that may have material anti-takeover consequences.
The
Board of Directors is not aware of any attempt, or contemplated attempt, to acquire control of the Company, and this proposal
is not being presented with the intent that it be utilized as a type of anti-takeover device or to secure management’s positions
within the Company.
EFFECTIVE
DATE OF INCREASE
Pursuant
to Rule 14c-2 under the Exchange Act, the Preferred Stock Transaction shall not be filed with the Secretary of State of Florida
until a date at least twenty (20) days after the date on which this Information Statement has been mailed to the Stockholders.
The Company anticipates that the action contemplated hereby will be effected on or about the close of business on August 26, 2019.
CONCLUSION
As
a matter of regulatory compliance, we are sending you this Information Statement, which describes the purpose and effect of the
above action. Your consent to the above action is not required and is not being solicited in connection with this action. This
Information Statement is intended to provide our Stockholders information required by the rules and regulations of the Securities
Exchange Act of 1934.
Signature
Pursuant
to the requirements of the Securities Exchange Act of 1934, The Greater Cannabis Company, Inc. has duly caused this report to
be signed by the undersigned hereunto authorized.
THE
GREATER CANNABIS COMPANY, INC.
|
|
|
|
By:
|
/s/
Aitan
Zacharin
|
|
|
Aitan
Zacharin
|
|
|
President,
CEO and Director
|
|
Greater Cannabis (PK) (USOTC:GCAN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Greater Cannabis (PK) (USOTC:GCAN)
Historical Stock Chart
From Apr 2023 to Apr 2024